TheSUBWAY.com announces the following stocks to its Hot Stocks List: Stem Cell Innovations, Inc. (OTCBB: SCLL), ARM (NASDAQ: ARMHY), Level 3 Communications (NASDAQ: LVLT), Biomet, Inc. (NASDAQ: BMET).

Stem Cell Innovations, Inc. (OTCBB: SCLL) and The ALS Association, a non-profit health organization dedicated to finding a cure for amyotrophic lateral sclerosis (ALS), just announced a two-year discovery alliance. Stem Cell Innovations (SCI) will develop human motor neuron models based on its proprietary PluriCell(TM) technology that can be used for high-throughput screening. Subsequently, the cell models will be used by alliance partner Galapagos to discover novel drug targets for ALS. Under the terms of the agreement, SCI will receive 400,000 Euros ($512,000) from The ALS Association, upon completion of certain milestones. In addition, SCI has the option to further develop certain cell-therapy applications based on results identified in the program.

Other stocks highlighted include ARM (NASDAQ: ARMHY): Hot Stocks List, down 1% on 1 million shares, Level 3 Communications (NASDAQ: LVLT): Hot Stocks List, down 1% on 1 million shares, Biomet, Inc. (NASDAQ: BMET): Hot Stocks List, up 1% on 2 million shares.

"Federal Reserve policymakers left interest rates unchanged after their meeting on September 20, for a second straight time, signaling that the central bank doesn't believe inflation is an immediate threat at the moment and that growth in the economy has slowed to a moderate pace. A sharp drop in oil prices has helped stem inflation fears, although the core rate is more closely watched by the Federal Open Market Committee." More is available at: http://www.thesubway.com.

TheSUBWAY.com's Daily Stock Updates:

TheSUBWAY.com, a leader in corporate communications and finance, highlights stocks that are in the news, have traded high volume, or experienced a large change in price in recent sessions. The aforementioned commentary is not meant to be indicative of a "long term" view of any of the companies listed. For more go to http://www.thesubway.com.

All material herein was prepared by Capital Research Group, Inc. (CRG) based upon information believed to be reliable. The information contained herein is not guaranteed by CRG to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.thesubway.com or mentioned herein. CRG has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion. CRG has been compensated fifty thousand dollars for SCLL. CRG intends to sell its shares. CRG has sold approximately zero SCLL shares to date. CRG may sell its shares for less than the target price given in this opinion. In addition to any compensation mentioned above, additional compensation can be equal to ten percent of any newly issued or registered securities of the profiled companies. CRG's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. CRG will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.